Posts Tagged ‘research’

An Objective Line Between Processed and Ultra-Processed

May 23, 2019 — Objectivity is tough. For a case in point, let’s look at how people are processing new data from Kevin Hall and colleagues on ultra-processed foods. It’s important. For the first time, we have good data to say that these foods can cause weight gain. Before we had speculation. Now we have good, experimental evidence. Some […]

Genes Are Not Destiny? What’s That Supposed to Mean?

April 19, 2019 — Facts are stubborn because they’re real. Two new studies in Cell today shine a light on a basic fact about obesity that we’ve known for decades. Obesity is a highly heritable condition. Roughly 70 percent of a person’s risk of obesity is driven by the genes they inherit. But some people work awfully hard to […]

Intercept Presents Encouraging NASH Results

April 12, 2019 — It’s been a long road for Intercept Pharmaceuticals to develop an important advance for treating NASH (non-alcoholic steatohepatitis). Five years ago this little startup company shocked the world when a monitoring board stopped a placebo-controlled study because their drug (obeticholic acid or OCA) had worked so well. A final round of 64 liver biopsies were […]

Metabolic Surgery: Changing Hearts and Minds

April 9, 2019 — The logic is inescapable. Type 2 diabetes is a cruel, progressive disease that slowly, but surely destroys a body from the inside out.Strokes, heart disease, amputations, organ failure – they’re all part of a bleak picture. Intensive medical care can slow it down. But metabolic surgery can put it into remission. Three years ago, a […]

Poor Diets Cause One Fifth of the World’s Deaths?

April 4, 2019 — It’s a impressive factoid. According to a new study in Lancet, poor diets are a factor in one fifth of the world’s deaths every year. The biggest culprits are too much salt, along with too little fruit and whole grains. All of this comes from the Global Burden of Disease project at the University of […]

News from The Endocrine Society on Oral Semaglutide

March 26, 2019 — If you talk to researchers and clinicians deeply involved in the future of obesity treatment, you will find quite a buzz about a type 2 diabetes drug called semaglutide. It’s a cousin of the most successful new drug for treating obesity – liraglutide. Right now, both of these drugs are sold only as an injection. […]

On the Hunt for Precision Personalized Diets

March 13, 2019 — Precision nutrition is a concept with an almost irresistible allure. It borrows on the cachet of precision medicine. On top of that, frustration with the presently imprecise nature of nutrition science makes the promise of precision personalized diets especially appealing. So in pursuit of this idea, a new study in Nutrients offers some tantalizing clues. […]

Childhood Obesity: Talking Crisis While Acting Casually

March 12, 2019 — Crisis. It’s a time of intense difficulty. Or it’s a time when a difficult, important decision must be made. And finally, it can be a turning point toward either failure or recovery. For decades now, all the talk about childhood obesity has been about crisis. That crisis talk is spreading around the world as childhood […]

PREDIMED and the “Corpse” of Nutrition Science

February 14, 2019 — Last year, the New England Journal of Medicine retracted and then published a revised analysis of the landmark PREDIMED study. With that action, it shook the world of nutrition science. Even now, there’s still a whole lot of shakin going on. What About 267 Secondary Publications? Just last week in the BMJ, Arnav Agarwal and John […]

What Presidential Checkups Tell Us About Self-Reports

February 13, 2019 — Our president just had his annual medical exam and that ritual is providing us an important reminder. Self-reports – especially about obesity, nutrition, and physical activity – are not very reliable. That’s because most people misremember or shade the truth. We’re all lighter, taller, eating healthier, and more active when we do the reporting ourselves. A Long […]